Oliver W. Press, MD, PhD
Professor of Medicine, University of Washington
BS in Biology with Departmental Distinction,
Stanford University, 1973
PhD in Biological Structure, University of Washington, 1977
MD, University of Washington,1979
Oliver W. Press, MD, PhD, is a Member of the Fred Hutchinson Cancer Research Center (FHCRC) and a Professor of Medicine at the University of Washington (UW). Dr. Press received both his MD and PhD from the University of Washington after completing his undergraduate studies at Stanford University. He performed an internship and residency at Massachusetts General Hospital and served as a clinical fellow at Harvard Medical School. He is currently the recipient of the Dr. Penny E. Petersen Memorial Chair for Lymphoma Research at FHCRC and served as Associate Director of the University of Washington Medical Scientist Training Program for over 15 years. He was also the Director of Clinical Research for Hematology and Hematologic Malignancies for the UW/FHCRC Cancer Center Consortium from 2006 to 2008. He is currently the Co-Director of the UW Center for Intracellular Delivery of Biologics. Dr. Press has recently been chosen by his peers to be the Co-Chair of Lymphoma Steering Committee of the National Cancer Institute and has served as the Chair of the Scientific Advisory Board of the Lymphoma Research Foundation (2006 to 2008) and of the Follicular Lymphoma Consortium (2008 to present).
Dr. Press conducts both laboratory and clinical research using immunotherapeutic approaches to treat lymphomas and leukemias in a wide variety of cellular assays, mouse and primate models and human clinical trials and has served as the P.I. on multiple NIH R01, R21, U01 and P01 grants as well as awards from the Leukemia and Lymphoma Society, the Lymphoma Research Foundation, the Multiple Myeloma Research Foundation, the Life Sciences Discovery Fund and many other organizations.
Dr. Press has published more than 200 research articles on immunotherapy of hematologic malignancies in journals such as The New England Journal of Medicine, The Journal of Experimental Medicine, Blood, Cancer Research, The Journal of Clinical Oncology, and Lancet.